We are currently enrolling participants for a home-based clinical trial investigating two CBD Oil formulations in the treatment of PTSD. Eligible participants will be randomly assigned (like a flip of a coin) to one of the following 8 week treatments: (a) CBD oil isolate, (b) CBD oil broad spectrum, or (c) placebo oil. All study procedures (assessment and treatment) are conducted at your home using a smart phone, tablet, or computer connected to the Internet. All participants will receive 8 weeks of CBD oil at no cost.
IRB Approved: Mar 3, 2020 (#2019-05-0123)
• Meets for a current DSM-5 diagnosis of PTSD as their “primary” mental disorder
• Age between 18 to 70
• Fluent in English
• Able to arrange transportation to our laboratory
• Has access to the internet
• Willingness to provide signed informed consent
• Willingness to refrain from all non-study cannabis use during the study period
• History of a suicide attempt within the past 6 months;
• Any medical problem that would preclude participating in the study including liver disease;
• Current use of warfarin or other prescribed blood thinners;
• Currently taking seizure medications such as valproate, lamotrigine, or clobazam;
• Currently taking thyroid medications such as levothyroxine;
• Currently taking heart rhythm medications such as amiodarone;
• Pregnant or planning to become pregnant within the next 6 weeks;
• History of current alcohol or substance use disorder within the past month;
• History of psychosis within the past six months;
• History of adverse reaction to CBD oil or other CBD products;
• Allergic to coconut oil
